{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:09:14Z","timestamp":1783764554053,"version":"3.55.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":734,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170385"],"award-info":[{"award-number":["82170385"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1908209"],"award-info":[{"award-number":["U1908209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170385"],"award-info":[{"award-number":["82170385"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1908209"],"award-info":[{"award-number":["U1908209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>We conducted a presentation on an 84-year-old male patient who has been diagnosed with TTRA81V (p. TTRA101V) hereditary transthyretin cardiac amyloidosis (hATTR-CM). In order to establish its pathogenicity, we extensively investigated the biochemical and biophysical properties of the condition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly acknowledged progressive infiltrative cardiomyopathy that leads to heart failure and potentially fatal arrhythmias. Gaining a comprehensive understanding of the biochemical and biophysical characteristics of genetically mutated TTR proteins serves as the fundamental cornerstone for delivering precise medical care to individuals affected by ATTR. Laboratory assessments indicated a brain natriuretic peptide of 200.12 ng\/L (normal range: 0\u2013100 ng\/L) and high-sensitivity cardiac troponin I of 0.189 \u03bcg\/L (normal range: 0\u20130.1 \u03bcg\/L). Echocardiography identified left atrial enlargement, symmetrical left ventricular hypertrophy (16 mm septal and 16 mm posterior wall), and a left ventricular ejection fraction of 56%. Cardiac-enhanced magnetic resonance imaging revealed subendocardial late gadolinium enhancement. Tc-99m-PYP nuclear scintigraphy confirmed grade 3 myocardial uptake, showing an increased heart-to-contralateral ratio (H\/CL = 2.33). Genetic testing revealed a heterozygous missense mutation in the TTR gene (c.302C&amp;gt;T), resulting in an alanine-to-valine residue change (p. Ala81Val, following the first 20 residues of signal sequence nomenclature). Biochemical analysis of this variant displayed compromised kinetic stability in both the TTRA81V:WT (wild-type) heterozygote protein (half-life, t1\/2 = 21 h) and the TTRA81V homozygote protein (t1\/2 = 17.5 h). The kinetic stability fell between that of the TTRWT (t1\/2 = 42 h) and the early-onset TTRL55P mutation (t1\/2 = 4.4 h), indicating the patient's late-onset condition. Kinetic stabilizers (Tafamidis, Diflunisal, and AG10) all exhibited the capacity to inhibit TTRA81V acid- and mechanical force-induced fibril formation, albeit less effectively than with TTRWT. Chromatographic assessment of the patient's serum TTR tetramers indicated a slightly lower concentration (3.0 \u03bcM) before oral administration of Tafamidis compared with the normal range (3.6\u20137.2 \u03bcM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified a patient with hATTR-CM who possesses a rare TTRA81V mutation solely associated with cardiac complications. The slightly reduced kinetic stability of this mutation indicates its late-onset nature and contributes to the gradual progression of the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14543","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T19:24:53Z","timestamp":1697138693000},"page":"112-125","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Biochemical and Biophysical Properties of a Rare TTRA81V Mutation Causing Mild Transthyretin Amyloid Cardiomyopathy"],"prefix":"10.1093","volume":"11","author":[{"given":"Qiuyan","family":"Sha","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Dalian Medical University , 222 Zhongshan Road, Dalian, Liaoning ,","place":["China"]},{"name":"CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Science , Dalian, Liaoning ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Dalian Medical University , 222 Zhongshan Road, Dalian, Liaoning ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdie","family":"Wang","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Science , Dalian, Liaoning ,","place":["China"]},{"name":"University of Chinese Academy of Sciences , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Sun","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Science , Dalian, Liaoning ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Dalian Medical University , 222 Zhongshan Road, Dalian, Liaoning ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Dalian Medical University , 222 Zhongshan Road, Dalian, Liaoning ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Dalian Medical University , 222 Zhongshan Road, Dalian, Liaoning ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[{"name":"CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Science , Dalian, Liaoning ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Dalian Medical University , 222 Zhongshan Road, Dalian, Liaoning ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"key":"2026012113075301400_ehf214543-bib-0001","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"2026012113075301400_ehf214543-bib-0002","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.7754382","article-title":"Structure of a complex of two plasma proteins: Transthyretin and retinol-binding protein","volume":"268","author":"Monaco","year":"1995","journal-title":"Science"},{"key":"2026012113075301400_ehf214543-bib-0003","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","article-title":"The biological and chemical basis for tissue-selective amyloid disease","volume":"121","author":"Sekijima","year":"2005","journal-title":"Cell"},{"key":"2026012113075301400_ehf214543-bib-0004","doi-asserted-by":"publisher","first-page":"16427","DOI":"10.1073\/pnas.202495199","article-title":"Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity","volume":"99","author":"Hammarstr\u00f6m","year":"2002","journal-title":"PNAS"},{"key":"2026012113075301400_ehf214543-bib-0005","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.pcad.2009.11.007","article-title":"Amyloid heart disease","volume":"52","author":"Falk","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"key":"2026012113075301400_ehf214543-bib-0006","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jchf.2019.04.010","article-title":"Screening for transthyretin amyloid cardiomyopathy in everyday practice","volume":"7","author":"Witteles","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2026012113075301400_ehf214543-bib-0007","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-med-052918-020140","article-title":"Cardiac amyloidosis: Overlooked, underappreciated, and treatable","volume":"71","author":"Rubin","year":"2020","journal-title":"Annu Rev Med"},{"key":"2026012113075301400_ehf214543-bib-0008","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012113075301400_ehf214543-bib-0009","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026012113075301400_ehf214543-bib-0010","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.120.052136","article-title":"Prevalence of atrial fibrillation and thromboembolic risk in wild-type transthyretin amyloid cardiomyopathy","volume":"143","author":"Bukhari","year":"2021","journal-title":"Circulation"},{"key":"2026012113075301400_ehf214543-bib-0011","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ Heart Fail"},{"key":"2026012113075301400_ehf214543-bib-0012","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrd3675","article-title":"Tafamidis","volume":"11","author":"Said","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"2026012113075301400_ehf214543-bib-0013","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/01.wnl.0000429338.33391.87","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial","volume":"80","author":"Merkies","year":"2013","journal-title":"Neurology"},{"key":"2026012113075301400_ehf214543-bib-0014","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","author":"Ando","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"2026012113075301400_ehf214543-bib-0015","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/jnnp-2014-308724","article-title":"Transthyretin (ATTR) amyloidosis: Clinical spectrum, molecular pathogenesis and disease-modifying treatments","volume":"86","author":"Sekijima","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026012113075301400_ehf214543-bib-0016","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jacc.2019.03.012","article-title":"Transthyretin stabilization by AG10 in symptomatic transthyretin amyloid cardiomyopathy","volume":"74","author":"Judge","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026012113075301400_ehf214543-bib-0017","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nrd.2016.226","article-title":"RNAi hits another rut","volume":"15","author":"Mullard","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"2026012113075301400_ehf214543-bib-0018","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"Gertz","year":"2015","journal-title":"JACC"},{"key":"2026012113075301400_ehf214543-bib-0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2022.105313","article-title":"Transthyretin: Its function and amyloid formation","volume":"155","author":"Ueda","year":"2022","journal-title":"Neurochem Int"},{"key":"2026012113075301400_ehf214543-bib-0020","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026012113075301400_ehf214543-bib-0021","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1021\/ar020073i","article-title":"Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: A focus on the transthyretin amyloidoses","volume":"38","author":"Johnson","year":"2005","journal-title":"Acc Chem Res"},{"key":"2026012113075301400_ehf214543-bib-0022","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1021\/bi500171j","article-title":"Quantification of transthyretin kinetic stability in human plasma using subunit exchange","volume":"53","author":"Rappley","year":"2014","journal-title":"Biochemistry"},{"key":"2026012113075301400_ehf214543-bib-0023","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3233\/JND-210656","article-title":"Hereditary transthyretin amyloidosis\u2014Clinical and genetic characteristics of a multiracial South-East Asian cohort in Singapore","volume":"8","author":"Chen","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"2026012113075301400_ehf214543-bib-0024","doi-asserted-by":"publisher","first-page":"985","DOI":"10.5603\/CJ.a2020.0104","article-title":"Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis","volume":"29","author":"Gawor","year":"2022","journal-title":"J Neuromuscul Dis Cardiol J"},{"key":"2026012113075301400_ehf214543-bib-0025","doi-asserted-by":"publisher","first-page":"549","DOI":"10.6515\/ACS.202109_37(5).20210422A","article-title":"Transthyretin amyloid cardiomyopathy associated with Ala81Val transthyretin mutation: A case report","volume":"37","author":"Tseng","year":"2021","journal-title":"Acta Cardiol Sin"},{"key":"2026012113075301400_ehf214543-bib-0026","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1021\/acs.biochem.8b00642","article-title":"NMR measurements reveal the structural basis of transthyretin destabilization by pathogenic mutations","volume":"57","author":"Leach","year":"2018","journal-title":"Biochemistry"},{"key":"2026012113075301400_ehf214543-bib-0027","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.15252\/emmm.201505357","article-title":"A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis","volume":"7","author":"Marcoux","year":"2015","journal-title":"EMBO Mol Med"},{"key":"2026012113075301400_ehf214543-bib-0028","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1073\/pnas.1317488111","article-title":"Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis","volume":"111","author":"Mangione","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026012113075301400_ehf214543-bib-0029","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/13506129.2020.1808783","article-title":"Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma","volume":"28","author":"Nelson","year":"2021","journal-title":"Amyloid"},{"key":"2026012113075301400_ehf214543-bib-0030","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1006\/jmbi.1998.1937","article-title":"Protein subunit interactions and structural integrity of amyloidogenic transthyretins: Evidence from electrospray mass spectrometry","volume":"281","author":"Nettleton","year":"1998","journal-title":"J Mol Biol"},{"key":"2026012113075301400_ehf214543-bib-0031","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/13506120802525285","article-title":"Serum transthyretin levels in senile systemic amyloidosis: Effects of age, gender and ethnicity","volume":"15","author":"Buxbaum","year":"2008","journal-title":"Amyloid"},{"key":"2026012113075301400_ehf214543-bib-0032","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004000","article-title":"Use of serum transthyretin as a prognostic indicator and predictor of outcome in cardiac amyloid disease associated with wild-type transthyretin","volume":"11","author":"Hanson","year":"2018","journal-title":"Circ Heart Fail"},{"key":"2026012113075301400_ehf214543-bib-0033","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071768","article-title":"Transthyretin: From structural stability to osteoarticular and cardiovascular diseases","volume":"10","author":"Wieczorek","year":"2021","journal-title":"Cell"},{"key":"2026012113075301400_ehf214543-bib-0034","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092360","article-title":"New advanced imaging parameters and biomarkers\u2014A step forward in the diagnosis and prognosis of TTR cardiomyopathy","volume":"11","author":"Rimbas","year":"2022","journal-title":"J Clin Med"},{"key":"2026012113075301400_ehf214543-bib-0035","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N Engl J Med"},{"key":"2026012113075301400_ehf214543-bib-0036","doi-asserted-by":"publisher","first-page":"P28","DOI":"10.1186\/1750-1172-10-S1-P28","article-title":"Five novel TTR variants: Associated phenotypes and structural consequences","volume":"10","author":"Rowczenio","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"2026012113075301400_ehf214543-bib-0037","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.830006","article-title":"Amyloid formation by globular proteins: The need to narrow the gap between in vitro and in vivo mechanisms","volume":"9","author":"Faravelli","year":"2022","journal-title":"Front Mol Biosci"},{"key":"2026012113075301400_ehf214543-bib-0038","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002558","article-title":"Transthyretin cardiac amyloidosis in Black Americans","volume":"9","author":"Shah","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026012113075301400_ehf214543-bib-0039","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1073\/pnas.091431798","article-title":"Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma","volume":"98","author":"Purkey","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026012113075301400_ehf214543-bib-0040","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.1003303","article-title":"Clinical and biochemical characterization of hereditary transthyretin amyloidosis caused by E61K mutation","volume":"15","author":"Chu","year":"2022","journal-title":"Front Mol Neurosci"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/1\/112\/64508998\/eschf_11_1_112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/1\/112\/64508998\/eschf_11_1_112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:08:23Z","timestamp":1769018903000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/1\/112\/8268250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,10,12]]},"published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14543","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2023,10,12]]},"assertion":[{"value":"2023-01-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}